Acquiring French dietary supplements specialist Arkopharma Group in January helped Germany’s Dermapharm Holding to post a 10.8% rise in sales to €1.14bn ($1.23bn) in 2023.
The addition of Arkopharma more than offset a drop off in revenues from COVID-19 vaccine production